[
  {
    "ts": null,
    "headline": "Eli Lilly (LLY) Stock Moves -0.27%: What You Should Know",
    "summary": "Eli Lilly (LLY) concluded the recent trading session at $822.51, signifying a -0.27% move from its prior day's close.",
    "url": "https://finnhub.io/api/news?id=95d394236f95c12e0d7b307d991e16319dfbafdef343ddfd6a1198c6148e058d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742334315,
      "headline": "Eli Lilly (LLY) Stock Moves -0.27%: What You Should Know",
      "id": 133324416,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (LLY) concluded the recent trading session at $822.51, signifying a -0.27% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=95d394236f95c12e0d7b307d991e16319dfbafdef343ddfd6a1198c6148e058d"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Large Cap Focus Growth V.I. Fund Q4 2024 Commentary",
    "summary": "The fund posted a return of 6.12% (Class I shares) for the fourth quarter of 2024. The largest exposures were in the IT, consumer discretionary, and communication services sectors.",
    "url": "https://finnhub.io/api/news?id=97cf50d37ed98fdb7cc4234b9fbfd82c53fdb3809751a6e52bfa678f67792145",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742333460,
      "headline": "BlackRock Large Cap Focus Growth V.I. Fund Q4 2024 Commentary",
      "id": 133236561,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367307622/image_1367307622.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The fund posted a return of 6.12% (Class I shares) for the fourth quarter of 2024. The largest exposures were in the IT, consumer discretionary, and communication services sectors.",
      "url": "https://finnhub.io/api/news?id=97cf50d37ed98fdb7cc4234b9fbfd82c53fdb3809751a6e52bfa678f67792145"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly And Company (LLY): Among Stocks to Buy That May Be Splitting Soon",
    "summary": "We recently published a list of the 12 Stocks to Buy That May Be Splitting Soon. In this article, we are going to take a look at where Eli Lilly And Company (NYSE:LLY) stands against other stocks that may be splitting soon. Stock splits change the number of outstanding shares of a company, but not […]",
    "url": "https://finnhub.io/api/news?id=e30a0bb5fc611f453951d01ecc006cbce9b6e307787f1c6adf4ac6127e90d8a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742332013,
      "headline": "Eli Lilly And Company (LLY): Among Stocks to Buy That May Be Splitting Soon",
      "id": 133324417,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of the 12 Stocks to Buy That May Be Splitting Soon. In this article, we are going to take a look at where Eli Lilly And Company (NYSE:LLY) stands against other stocks that may be splitting soon. Stock splits change the number of outstanding shares of a company, but not […]",
      "url": "https://finnhub.io/api/news?id=e30a0bb5fc611f453951d01ecc006cbce9b6e307787f1c6adf4ac6127e90d8a4"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly (NYSE:LLY) Welcomes Circular Genomics To Gateway Labs For Advancing Alzheimer's Biomarker Research",
    "summary": "Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease diagnostics capabilities using advanced circRNA technologies. Eli Lilly (NYSE:LLY) experienced a 6% price increase over the last quarter, coinciding with this strategic move. The company also expanded its research collaboration with AdvanCell to develop targeted cancer therapies and formed a venture capital fund aimed at therapeutic platform innovation. Additionally, positive...",
    "url": "https://finnhub.io/api/news?id=7ed384825bfd65ba0ca6988221776817a2d2ab6b62bf479ca80ae8f555a346aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742320332,
      "headline": "Eli Lilly (NYSE:LLY) Welcomes Circular Genomics To Gateway Labs For Advancing Alzheimer's Biomarker Research",
      "id": 133324418,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease diagnostics capabilities using advanced circRNA technologies. Eli Lilly (NYSE:LLY) experienced a 6% price increase over the last quarter, coinciding with this strategic move. The company also expanded its research collaboration with AdvanCell to develop targeted cancer therapies and formed a venture capital fund aimed at therapeutic platform innovation. Additionally, positive...",
      "url": "https://finnhub.io/api/news?id=7ed384825bfd65ba0ca6988221776817a2d2ab6b62bf479ca80ae8f555a346aa"
    }
  },
  {
    "ts": null,
    "headline": "Is Eli Lilly and Company (LLY) the Best Diabetes Stock to Buy According to Billionaires?",
    "summary": "We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best diabetes stocks to buy according to billionaires. The Growing Market and Innovation in Continuous Glucose Monitoring (CGM) Technology The […]",
    "url": "https://finnhub.io/api/news?id=f3aff36fac934f46d2d727f43da53c458c980531ed4ce9ecb2651a5ffef754ae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742319567,
      "headline": "Is Eli Lilly and Company (LLY) the Best Diabetes Stock to Buy According to Billionaires?",
      "id": 133324419,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best diabetes stocks to buy according to billionaires. The Growing Market and Innovation in Continuous Glucose Monitoring (CGM) Technology The […]",
      "url": "https://finnhub.io/api/news?id=f3aff36fac934f46d2d727f43da53c458c980531ed4ce9ecb2651a5ffef754ae"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Says Eli Lilly And Co (LLY) Sellers Are ‘Uninformed’",
    "summary": "We recently published a list of 10 Jim Cramer Stocks to Watch This Month. In this article, we are going to take a look at where Eli Lilly And Co (NYSE:LLY) stands against other stocks that Jim Cramer discusses. Jim Cramer recently talked about the market selloff and how years of profits are lost within […]",
    "url": "https://finnhub.io/api/news?id=f1c3620036de875df098c1d9433780de267638b7068cca9c85c3666d06e81efe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742302091,
      "headline": "Jim Cramer Says Eli Lilly And Co (LLY) Sellers Are ‘Uninformed’",
      "id": 133324420,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Jim Cramer Stocks to Watch This Month. In this article, we are going to take a look at where Eli Lilly And Co (NYSE:LLY) stands against other stocks that Jim Cramer discusses. Jim Cramer recently talked about the market selloff and how years of profits are lost within […]",
      "url": "https://finnhub.io/api/news?id=f1c3620036de875df098c1d9433780de267638b7068cca9c85c3666d06e81efe"
    }
  }
]